Article Details
Retrieved on: 2024-08-20 17:31:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
On Tuesday, Stifel adjusted its price target for Cue Biopharma (NASDAQ:CUE) shares, reducing it to $4.00 from the previous $8.00.
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here